What This Bill Does · Plain English
Summary · Congress.gov
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 This bill authorizes grants to support early detection of and intervention for uterine fibroids. Uterine fibroids are tumors in the wall of the uterus that are usually benign but can cause painful and heavy menstrual bleeding and other symptoms. The bill requires the Department of Health and Human Services (HHS) to (1) conduct or support research on increasing early detection of and medical intervention for uterine fibroids, and (2) formulate strategies to increase early detection based on such research. Also, the bill authorizes HHS to provide grants to states to increase early detection of and intervention for uterine fibroids (e.g., screenings) and to carry out public awareness campaigns. Additionally, the bill authorizes HHS to provide grants to states for research relating to (1) disparities in pain management in uterine fibroid surgical treatment; or (2) uterine health conditions, as determined appropriate by HHS. HHS must report to Congress every two years on the activities funded by grants under the bill, including findings from the research conducted by states.
Action Timeline
2026-03-19
Committee on Health, Education, Labor, and Pensions. Hearings held.
2025-07-30
Introduced in Senate
2025-07-30
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Frequently Asked Questions
Did S.2531 pass?
S.2531 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
What does S.2531 do?
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 This bill authorizes grants to support early detection of and intervention for uterine fibroids. Uterine fibroids are tumors in the wall of the uterus that are usually benign but can cause painful and heavy menstrual bleeding and other symptoms. The bill requires the Department of Health and Human Services (HHS) to (1) conduct or support research on increasing early detection of and medical intervention for uterine fibroids, and (2) formulate strategies to increase early detection based on such research. Also, the bill…
Who sponsored S.2531?
S.2531 was sponsored by Angela D. Alsobrooks (D-Maryland).
Full Bill Text
119 S2531 IS: Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 U.S. Senate 2025-07-30 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. II 119th CONGRESS 1st Session S. 2531 IN THE SENATE OF THE UNITED STATES July 30, 2025 Ms. Alsobrooks (for herself and Ms. Lummis ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes. 1. Short title This Act may be cited as the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 . 2. Research on uterine fibroid early detection and intervention (a) In general The Secretary of Health and Human Services (referred to in this Act as the Secretary ) shall— (1) conduct or support research on increasing early detection of, and intervention for, uterine fibroids; and (2) based on the results of such research and other relevant information, formulate evidence-based or evidence-informed strategies to increase early detection in health care settings. (b) Timeline The Secretary shall finalize the evidence-based or evidence-informed strategies required by subsection (a)(2) as expeditiously as possible in order to make such strategies available to grantees under section 3 to implement such strategies pursuant to section 3(b)(3). 3. Grants with respect to uterine fibroid early detection and intervention (a) In general The Secretary may award grants to States for carrying out programs— (1) to increase early detection of, and intervention for, uterine fibroids; and (2) to develop and implement public awareness and education campaigns for the early detection of, and intervention for, uterine fibroids. (b) Use of funds A State receiving a grant under this section may use the grant for the following activities, with respect to increasing early detection of, and intervention for, uterine fibroids: (1) Screening procedures, including advanced gynecological imaging, including payment for such procedures. (2) Patient navigation services. (3) Implementation of evidence-based or evidence-informed strategies formulated under section 2(a)(2). (4) Facilitating access to health care settings. 4. Research with respect to uterine fibroid early detection and intervention The Secretary may award grants to States for the purpose of conducting research, which may include clinical trials, related to— (1) disparities in pain control and management in uterine fibroid surgical treatment; or (2) Asherman’s Syndrome, intrauterine adhesions, and other intrauterine conditions, as the Secretary determines appropriate. 5. Reports to Congress (a) Reports on grants Not later 2 years after the initial award of grants under section 2 or 3, and every 2 years thereafter, the Secretary shall submit to Congress, and make publicly available on the website of the Department of Health and Human Services— (1) a report summarizing the findings and results of programs and activities funded through grants awarded under this Act; and (2) a report outlining research developments and findings related to— (A) disparities in pain control and management in uterine fibroid surgical treatment; and (B) Asherman’s Syndrome, intrauterine adhesions, and other intrauterine conditions, as the Secretary determines appropriate.
Loading intelligence layer…